Search research articles
Contact Us
Filters
Showing results (51-60 of 57) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 57 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
July 9, 2010
Urocortin 3 modulates social discrimination abilities via corticotropin-releasing hormone receptor type 2
Jan M Deussing, Johannes Breu, Claudia Kühne, et al.
Molecular Cancer Therapeutics
|
July 16, 2025
TUB-040, a homogenous and hydrophilic NaPi2b-targeting ADC with stably linked exatecan, exhibits long-lasting anti-tumor activity and a well-tolerated safety profile
Annette M Vogl, Saskia Schmitt, Isabelle Mai, et al.
Nature Neuroscience
|
January 13, 2015
Neddylation inhibition impairs spine development, destabilizes synapses and deteriorates cognition
Annette M Vogl, Marisa M Brockmann, Sebastian A Giusti, et al.
Nature Communications
|
January 19, 2026
Expanding the payload scope in antibody-drug conjugates by delivery of hydroxy-containing drugs through self-immolative phosphoramidates
Philipp Ochtrop, Anil P Jagtap, Jan G Felber, et al.
Nature Neuroscience
|
May 23, 2018
Chronic CRH depletion from GABAergic, long-range projection neurons in the extended amygdala reduces dopamine release and increases anxiety
Nina Dedic, Claudia Kühne, Mira Jakovcevski, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 30, 2021
Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings
Ursula M Vogl, Tomasz M Beer, Ian D Davis, et al.
European Urology
|
July 3, 2026
Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics
Stefano Fanti, Fabio Turco, Bertrand Tombal, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 57) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 57 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
July 9, 2010
Urocortin 3 modulates social discrimination abilities via corticotropin-releasing hormone receptor type 2
Jan M Deussing, Johannes Breu, Claudia Kühne, et al.
Molecular Cancer Therapeutics
|
July 16, 2025
TUB-040, a homogenous and hydrophilic NaPi2b-targeting ADC with stably linked exatecan, exhibits long-lasting anti-tumor activity and a well-tolerated safety profile
Annette M Vogl, Saskia Schmitt, Isabelle Mai, et al.
Nature Neuroscience
|
January 13, 2015
Neddylation inhibition impairs spine development, destabilizes synapses and deteriorates cognition
Annette M Vogl, Marisa M Brockmann, Sebastian A Giusti, et al.
Nature Communications
|
January 19, 2026
Expanding the payload scope in antibody-drug conjugates by delivery of hydroxy-containing drugs through self-immolative phosphoramidates
Philipp Ochtrop, Anil P Jagtap, Jan G Felber, et al.
Nature Neuroscience
|
May 23, 2018
Chronic CRH depletion from GABAergic, long-range projection neurons in the extended amygdala reduces dopamine release and increases anxiety
Nina Dedic, Claudia Kühne, Mira Jakovcevski, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 30, 2021
Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings
Ursula M Vogl, Tomasz M Beer, Ian D Davis, et al.
European Urology
|
July 3, 2026
Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics
Stefano Fanti, Fabio Turco, Bertrand Tombal, et al.
Page
of 6